Vaccination in older adults: development of an educational tool, Vaxisenior, in France.
about
Immunogenicity and safety results from a randomized multicenter trial comparing a Tdap-IPV vaccine (REPEVAX®) and a tetanus monovalent vaccine in healthy adults: new considerations for the management of patients with tetanus-prone injuries.Strategies implemented to address vaccine hesitancy in France: a review article.
P2860
Vaccination in older adults: development of an educational tool, Vaxisenior, in France.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Vaccination in older adults: development of an educational tool, Vaxisenior, in France.
@en
Vaccination in older adults: development of an educational tool, Vaxisenior, in France.
@nl
type
label
Vaccination in older adults: development of an educational tool, Vaxisenior, in France.
@en
Vaccination in older adults: development of an educational tool, Vaxisenior, in France.
@nl
prefLabel
Vaccination in older adults: development of an educational tool, Vaxisenior, in France.
@en
Vaccination in older adults: development of an educational tool, Vaxisenior, in France.
@nl
P2093
P2860
P356
P1476
Vaccination in older adults: development of an educational tool, Vaxisenior, in France.
@en
P2093
Christophe Trivalle
Claude Jeandel
Daniel Camus
Joel Belmin
Patrice Bourée
Pierre Veyssier
P2860
P356
10.1586/ERV.10.29
P433
P50
P577
2010-03-01T00:00:00Z